Iovance Biotherapeutics Inc
Ownership
Ownership Structure
Who owns Iovance Biotherapeutics Inc (IOVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 87.1% of the shares are freely tradable; institutional investors hold 67.5%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 6.86 | 31,080,505 | +5.3 | 03/31/2026 |
| Mhr Fund Management Llc | 6.39 | 28,967,103 | +0.0 | 03/31/2026 |
| Two Sigma Investments LLC | 4.20 | 19,010,697 | +38.9 | 06/30/2026 |
| State Street Corp | 3.85 | 17,448,108 | -13.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.67 | 16,617,737 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.58 | 11,700,844 | +0.0 | 03/31/2026 |
| The Goldman Sachs Group Inc | 1.93 | 8,760,060 | +1.8 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| State Street® SPDR® S&P® Biotech ETF | 3.38 | 15,295,591 | -1.1 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.99 | 13,533,234 | +0.3 | 07/31/2026 |
| iShares Russell 2000 ETF | 2.25 | 10,197,376 | -0.6 | 08/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Vogt Frederick G | Interim CEO & General Counsel | 595,447 | 5,954,470 $ | Sep 8, 2026 | direct |
| Puri Raj K. | Chief Regulatory Officer | 256,364 | 2,563,640 $ | Sep 8, 2026 | direct |
| Kirby Daniel Gordon | Chief Commercial Officer | 154,511 | 1,545,110 $ | Aug 10, 2026 | direct |
| Bilinsky Igor | Chief Operating Officer | 142,074 | 1,420,740 $ | Sep 8, 2026 | direct |
| Roche Corleen M. | Chief Financial Officer | 28,757 | 287,570 $ | Aug 6, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | Vogt Frederick G | Interim CEO & General Counsel | Other | 6,638 | 8.70 | 57,751 |
| Sep 8, 2026 | Vogt Frederick G | Interim CEO & General Counsel | Other | 15,626 | 0.00 | – |
| Sep 8, 2026 | Bilinsky Igor | Chief Operating Officer | Other | 3,976 | 8.70 | 34,591 |
| Sep 8, 2026 | Bilinsky Igor | Chief Operating Officer | Other | 7,813 | 0.00 | – |
| Sep 8, 2026 | Puri Raj K. | Chief Regulatory Officer | Other | 4,478 | 8.70 | 38,959 |
| Sep 8, 2026 | Puri Raj K. | Chief Regulatory Officer | Other | 9,766 | 0.00 | – |
| Sep 1, 2026 | Vogt Frederick G | Interim CEO & General Counsel | Other | 17,702 | 8.28 | 146,573 |
| Sep 1, 2026 | Vogt Frederick G | Interim CEO & General Counsel | Other | 41,669 | 0.00 | – |
| Sep 1, 2026 | Puri Raj K. | Chief Regulatory Officer | Other | 2,508 | 8.28 | 20,766 |
| Sep 1, 2026 | Puri Raj K. | Chief Regulatory Officer | Other | 5,470 | 0.00 | – |
| Sep 1, 2026 | Bilinsky Igor | Chief Operating Officer | Other | 4,472 | 8.28 | 37,028 |
| Sep 1, 2026 | Bilinsky Igor | Chief Operating Officer | Other | 8,789 | 0.00 | – |
| Aug 10, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | Other | 2,436 | 6.40 | 15,590 |
| Aug 10, 2026 | Kirby Daniel Gordon | Chief Commercial Officer | Other | 10,001 | 0.00 | – |
| Aug 6, 2026 | Roche Corleen M. | Chief Financial Officer | Other | 21,238 | 6.21 | 131,888 |
| Aug 6, 2026 | Roche Corleen M. | Chief Financial Officer | Other | 49,995 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.